Sivraj Muralikrishnan on Muck Rack

Sivraj Muralikrishnan

As seen in: ONCOLOGY journal
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sivraj

Contact Sivraj, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

FDA Clears IND For UGN-501 in Non-Muscle Invasive Bladder Cancer

|
By Roman Fabbricatore, Russ Conroy, Sivraj Muralikrishnan
| ONCOLOGY journal Verified
The FDA has cleared an investigational new drug application (IND) for the next-generation oncolytic virus UGN-501 in the treatment of patients with non-muscle invasive bladder cancer (NMIBC), according to a news release from the developer, UroGen Pharma.1 Moreover, a phase 1 study is expected to begin in the fourth quarter of 2026, which will evaluate the safety, tolerability, and feasibility of intravesical UGN-501 among patients with NMIBC.
Open in Who Shared Issue with article?

What Were the Top Head and Neck Cancer Highlights at ASCO 2026?

|
By Sivraj Muralikrishnan, Jessica Moore, Victoria Tiedemann
| ONCOLOGY journal Verified
The head and neck cancer treatment landscape continues to evolve with practice-changing data and promising early-phase developments.
Open in Who Shared Issue with article?

Sivraj Muralikrishnan, MD

|
By Sivraj Muralikrishnan
| ONCOLOGY journal Verified
Sivraj Muralikrishnan, MD Articles by Sivraj Muralikrishnan, MD Sivraj Muralikrishnan, MD, highlighted top head and neck cancer data from ASCO, including the KEYNOTE-689 trial and the novel mRNA degrader REM-422.
Open in Who Shared Issue with article?
See all 3 licensed articles (4 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified